chelsie rohrscheib.png 3
Chelsie E. Rohrscheib, BMedSc (Hons), Ph.D. Neuroscience
Overcoming Barriers to OSA Screening and Treatment Compliance in Mild to Moderate Patients

Dr. Chelsie Rohrscheib, Ph.D. is the head sleep expert and neuroscientist at Wesper, an at-home sleep technology company that aims to make screening for common sleep disorders, like sleep apnea, […]

Dr. Chelsie Rohrscheib, Ph.D. is the head sleep expert and neuroscientist at Wesper, an at-home sleep technology company that aims to make screening for common sleep disorders, like sleep apnea, easier and more accessible to patients around the globe. Prior to joining Wesper, Chelsie specialized in science sleep and evaluated the molecular mechanisms that control sleep in the brain and how sleep loss affects health. Following her research career, Chelsie oversaw clinical trials for the treatment of obstructive sleep apnea and other common sleep disorders. Chelsie is passionate about educating the public on topics related to sleep health and sleep disorders and enjoys working with patients to help them navigate their sleep improvement journey.

Course Description:
This presentation will examine common barriers preventing patients with mild-moderate OSA from receiving diagnosis and treatment. We will also discuss how a novel method of virtual care can eliminate many of the barriers patients face from screening to treatment, monitoring, and support.

Learning Objectives:
Identify barriers preventing individuals with mild OSA from receiving screening, diagnosis, and treatment.
Understand common reasons some patients with mild OSA receive an inconclusive diagnosis.
Learn about alternative screening methods to better identify individuals with mild OSA
Learn how access to long-term patient education and support translates to better health outcomes, with case study examples.

Conflicts: Wesper Employee